These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3334988)

  • 1. Nonrandom chromosome alterations in human malignant mesothelioma.
    Popescu NC; Chahinian AP; DiPaolo JA
    Cancer Res; 1988 Jan; 48(1):142-7. PubMed ID: 3334988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma.
    Taguchi T; Jhanwar SC; Siegfried JM; Keller SM; Testa JR
    Cancer Res; 1993 Sep; 53(18):4349-55. PubMed ID: 8364929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
    Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
    Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas.
    Kovacs G; Frisch S
    Cancer Res; 1989 Feb; 49(3):651-9. PubMed ID: 2910484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma.
    Spitz R; Hero B; Ernestus K; Berthold F
    Clin Cancer Res; 2003 Jan; 9(1):52-8. PubMed ID: 12538451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonrandom chromosome changes in malignant melanoma.
    Becher R; Gibas Z; Karakousis C; Sandberg AA
    Cancer Res; 1983 Oct; 43(10):5010-6. PubMed ID: 6883347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent cytogenetic aberrations in human ovarian carcinomas.
    Kiechle-Schwarz M; Bauknecht T; Schmidt J; Walz L; Pfleiderer A
    Cancer Detect Prev; 1995; 19(3):234-43. PubMed ID: 7750111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome 12 breakpoints are cytogenetically different in benign and malignant lipogenic tumors: localization of breakpoints in lipoma to 12q15 and in myxoid liposarcoma to 12q13.3.
    Mrózek K; Karakousis CP; Bloomfield CD
    Cancer Res; 1993 Apr; 53(7):1670-5. PubMed ID: 8453640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal deletion in patients with malignant pleural mesothelioma.
    Neragi-Miandoab S; Sugarbaker DJ
    Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):42-4. PubMed ID: 19346221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent chromosome alterations in non-small cell lung cancer.
    Matturri L; Lavezzi AM
    Eur J Histochem; 1994; 38(1):53-8. PubMed ID: 7517731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Codeletion of p15 and p16 in primary malignant mesothelioma.
    Xio S; Li D; Vijg J; Sugarbaker DJ; Corson JM; Fletcher JA
    Oncogene; 1995 Aug; 11(3):511-5. PubMed ID: 7630635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurring loss involving chromosomes 1, 3, and 22 in malignant mesothelioma: possible sites of tumor suppressor genes.
    Flejter WL; Li FP; Antman KH; Testa JR
    Genes Chromosomes Cancer; 1989 Nov; 1(2):148-54. PubMed ID: 2487155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple recurrent chromosomal breakpoints in mantle cell lymphoma revealed by a combination of molecular cytogenetic techniques.
    Salaverria I; Espinet B; Carrió A; Costa D; Astier L; Slotta-Huspenina J; Quintanilla-Martinez L; Fend F; Solé F; Colomer D; Serrano S; Miró R; Beà S; Campo E
    Genes Chromosomes Cancer; 2008 Dec; 47(12):1086-97. PubMed ID: 18709664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
    Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
    Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1p and 3p deletions in meningiomas without detectable aberrations of chromosome 22 identified by comparative genomic hybridization.
    Carlson KM; Bruder C; Nordenskjöld M; Dumanski JP
    Genes Chromosomes Cancer; 1997 Dec; 20(4):419-24. PubMed ID: 9408760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer.
    Teixeira MR; Pandis N; Bardi G; Andersen JA; Heim S
    Cancer Res; 1996 Feb; 56(4):855-9. PubMed ID: 8631024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome abnormalities in leukemia and lymphoma.
    Rowley JD
    Ann Clin Lab Sci; 1983; 13(2):87-94. PubMed ID: 6602585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity analysis defines a critical region in chromosome 1p22 commonly deleted in human malignant mesothelioma.
    Lee WC; Balsara B; Liu Z; Jhanwar SC; Testa JR
    Cancer Res; 1996 Oct; 56(19):4297-301. PubMed ID: 8813110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncovering novel inter- and intrachromosomal chromosome 1 aberrations in follicular lymphomas by using an innovative multicolor banding technique.
    Lestou VS; Gascoyne RD; Salski C; Connors JM; Horsman DE
    Genes Chromosomes Cancer; 2002 Jun; 34(2):201-10. PubMed ID: 11979554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome alterations associated with in vitro exposure of human fibroblasts to chemical or physical carcinogens.
    Popescu NC; Amsbaugh SC; Milo G; DiPaolo JA
    Cancer Res; 1986 Sep; 46(9):4720-5. PubMed ID: 3731122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.